TrialBritish journal of clinical pharmacology2019

Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy.

Candice Jamois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.